cancerdetection

Check-Cap Shares Double Following FDA Approval of C-Scan Device

Check-Cap Shares Double Following FDA Approval of C-Scan Device

Shares of Check-Cap LTD (NASDAQ: CHEK) more than doubled this morning following the U.S. Food and Drug Administration's (FDA) approval of the Company’s C-Scan Device. The Pharmaceutical Company, based in Isfiya, Israel, dedicates its resea..